Cell–cell interaction analyses have suggested that FOLR2+ TAMs may be drivers of immunosuppression in HCC due to their increased expression of immunomodulatory chemokines alongside a greater number of immunosuppressive interactions with Tregs in comparison with other TAM populations [17]. Here, FOLR2 is linked to hepatocellular carcinoma.